Successful use of argatroban as an anticoagulant in burn-related severe acquired antithrombin III deficiency after heparin failure.
Gorman
R
R
Gordan
L
L
Zumberg
M
M
Kitchens
C
C
D000061:Accidents, Home; D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use*; D020152:Antithrombin III Deficiency / Q000188:drug therapy* / Q000209:etiology; D001120:Arginine / Q000031:analogs & derivatives; D002056:Burns / Q000097:blood / Q000150:complications* / Q000628:therapy; D002317:Cardiovascular Agents / Q000627:therapeutic use; D003329:Coronary Vasospasm / Q000188:drug therapy / Q000209:etiology; D003646:Debridement; D004359:Drug Therapy, Combination; D005107:Explosions; D006801:Humans; D008297:Male; D010875:Pipecolic Acids / Q000627:therapeutic use*; D013449:Sulfonamides; D018487:Ventricular Dysfunction, Left / Q000188:drug therapy / Q000209:etiology; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D002317:Cardiovascular Agents; D010875:Pipecolic Acids; D013449:Sulfonamides; D014859:Warfarin; D001120:Arginine; C031942:argatroban